David is Professor of Kidney Medicine at University College London, UK and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust. He is a clinician scientist interested in the complications of chronic kidney disease, specifically those that increase the burden of cardiovascular disease and/or accelerate progression of kidney failure. He has participated in the development and management of several large-scale clinical trials testing lipid-lowering regimens, calcimimetics, sodium glucose cotransporter 2 inhibitors and hypoxia-inducible factor stabilisers in patients with chronic kidney disease. Other roles include Honorary Professorial Fellow of The George Institute (based in Sydney, Australia) with a remit to support this organisation’s clinical trials activities in Europe. David has been involved in the development of Clinical Practice Guidelines for several organisations, most recently for Kidney Disease: Improving Global Outcomes (KDIGO) He has served as KDIGO co-chair between 2012 and 2019. He is Past President of the UK Renal Association and past chair of the UK Renal Registry. Ongoing roles include National Specialty Lead for the UK National Institute for Health Research Clinical Research Network. Locally he heads up the clinical research team in the Department of Nephrology at the Royal Free Hospital.
